Where is there opportunity?
Everything we do is aimed at clarifying diagnosis and eliminating uncertainty for patients. The opportunities with genomics are endless, and we are paving the way so every patient will have the answers they seek.
Real People,
Real Science,
Real Answers.
JOHN HANNA
Chief Commercial Officer
Veracyte
This is the Age of Evidence.
Where a new definition of diagnostic truth is changing patient care as we know it. Where physicians and patients can now benefit from the evolution of healthcare and know, by design, the answers they seek.

Veracyte gives patients a clearer path for the future.

We are leading in the Age of Evidence.
our impact
The Age
of Evidence
Veracyte's genomic tests have the potential to save billions of dollars each year in unnecessary surgery costs.
Learn More >
Highlighted by National Cancer Institute
NCI highlights lung cancer early detection work behind Percepta in its annual plan
learn more >
Evidence That Sets New Standards
Veracyte’s CEO Receives 2017 Wallace H. Coulter Award for Healthcare Innovation

learn more >


latest news
news and updates
Nov 15, 2017
Veracyte to Present at the Piper Jaffray 29th Annual Healthcare Conference

learn more >
Nov 9, 2017
Veracyte Announces New Clinical Utility Data Suggesting Envisia Genomic Classifier Enables as Confident a Diagnosis in IPF as Surgical Pathology

learn more >
Nov 6, 2017
Veracyte Announces Third Quarter 2017 Financial Results

learn more >